The Importance of Monitoring Patients' Responses to Medications: Increased Arousal after Administration of Zolpidem in Those with Hypoxic Ischemic Encephalopathy-A Case Study.

Rehabil Nurs

Adjunct Faculty, Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL.

Published: February 2018

In rehabilitation, nurses are the first team members to note or be told when a patient is having a positive or negative response to a medication. In brain injury medicine, medications are often used to augment cognitive or physical rehabilitation by increasing alertness, attention, focus, concentration, improving sleep, decreasing agitation, or easing spasticity and rigidity. Rehabilitation nurses not only should be aware of how medications work but also how medications may work differently in a chronically ill or disabled population. This article describes a 51-year-old man who suffered a hypoxic ischemic brain injury and how his neurological complications were managed with a nonbenzodiazepine medication which the Food and Drug Administration approved for the treatment of insomnia.

Download full-text PDF

Source
http://dx.doi.org/10.1002/rnj.232DOI Listing

Publication Analysis

Top Keywords

hypoxic ischemic
8
rehabilitation nurses
8
brain injury
8
medications work
8
monitoring patients'
4
patients' responses
4
medications
4
responses medications
4
medications increased
4
increased arousal
4

Similar Publications

The impact of clinical seizures and adverse brain MRI patterns in neonates with hypoxic-ischemic encephalopathy and abnormal neurodevelopment.

Clinics (Sao Paulo)

January 2025

Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address:

Introduction: This study aimed to investigate the associations among seizures, clinical characteristics, and brain injury on Magnetic Resonance Imaging (MRI) in infants with Hypoxic Ischemic Encephalopathy (HIE), and to determine whether these findings can predict unfavorable neurodevelopmental outcomes.

Method: Clinical and electrographic seizures were assessed by amplitude-integrated electroencephalogram, and the extent of brain injury was evaluated by using MRI. At 12‒24 months of age, developmental impairment or death was assessed.

View Article and Find Full Text PDF

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the IL‑1 protein data shown in the western blotting data in Fig. 5A on p. 1905, the hippocampal images shown in Fig.

View Article and Find Full Text PDF

Therapeutic hypothermia in preterm infants under 36 weeks: Case series on outcomes and brain MRI findings.

Eur J Pediatr

January 2025

Neonatology Department. Hospital Sant Joan de Déu, Center for Maternal Fetal and Neonatal Medicine. Neonatal Brain Group, Universitat de Barcelona. Hospital Clínic, Universitat de Barcelona. BCNatal - Barcelona, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.

Purpose: Perinatal hypoxic-ischemic encephalopathy (HIE) is a significant cause of neonatal brain injury. Therapeutic hypothermia (TH) is the standard treatment for term neonates, but its safety and efficacy in neonates < 36 weeks gestational age (GA) remains unclear. This case series aimed to evaluate the outcomes of preterm infants with HIE treated with TH.

View Article and Find Full Text PDF
Article Synopsis
  • Neonatal hypoxic-ischemic encephalopathy (HIE) is a leading cause of death and disability in newborns, and caffeine has shown promise in mitigating its effects.
  • In a neonatal rat model, caffeine administration post-injury reduced brain damage and inflammation compared to controls, highlighting its potential benefits.
  • The study found that caffeine influences the AMPK/mTOR pathway, suggesting that targeting this pathway could enhance neuroprotection and improve outcomes for HIE, especially in regions lacking sufficient resources for treatment.
View Article and Find Full Text PDF

Hypoxic-ischemic brain injury (HIBD) is a major cause of neonatal mortality and long-term neurological deficits, with limited treatment options. Extracellular vesicles (EVs) from human umbilical cord mesenchymal stem cells (hUC-MSC-EVs) have shown promise in neuroprotection, but the mechanisms remain unclear. This study explores how hUC-MSC-EVs protect neonatal rats from HIBD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!